Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
258 studies found for:    Open Studies | "Cardiomyopathies"
Show Display Options
Rank Status Study
21 Not yet recruiting Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients; Comparison of : Global Longitudinal Strain vs. Left Ventricule Ejection Fruction
Condition: Cardiomyopathy
Intervention: Device: echocardiography
22 Recruiting Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
Condition: Primary Idiopathic Dilated Cardiomyopathy
Interventions: Other: bone marrow-derived MSCs injection;   Other: placebo intervention
23 Not yet recruiting Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
Conditions: Chagas Cardiomyopathy;   Non-sustained Ventricular Tachycardia;   At Least 10 Points in Rassi Risk Score for Death
Interventions: Procedure: ICD implantation;   Drug: amiodarone hydrochloride
24 Unknown  Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: umbilical cord mesenchymal stem cells
25 Unknown  Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Intervention:
26 Not yet recruiting Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Perhexiline;   Drug: Placebo
27 Recruiting Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes
Conditions: Heart Diseases;   Cardiac Arrhythmias;   Ventricular Premature Complexes;   Systolic Heart Failure;   Cardiomyopathies
Intervention: Other: PVC suppression therapy
28 Recruiting Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response
Conditions: Hypertrophic Cardiomyopathy;   Mechanical Hyper-synchronicity
Interventions: Procedure: Echocardiography (TEE);   Device: Magnetic resonance imaging (MRI) with gadolinium enhancement;   Device: Magnetic resonance imaging (MRI) without gadolinium enhancement;   Procedure: 3D electrocardiographic mapping (ECM)
29 Recruiting The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Condition: Cardiomyopathy
Intervention: Drug: Ranolazine
30 Recruiting HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)
Conditions: Duchenne Muscular Dystrophy;   Cardiomyopathy
Intervention: Drug: Allogeneic Cardiosphere-Derived Cells (CAP-1002)
31 Unknown  CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone
Condition: Cardiomyopathy
Interventions: Drug: Eplerenone;   Drug: Placebo
32 Recruiting Effects of Levosimendan and Milrinone on Left and Right Ventricular Function in Septic Cardiomyopathy
Conditions: Septic Shock;   Cardiomyopathy
Interventions: Drug: Levosimendan;   Drug: Milrinone
33 Recruiting Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy
Condition: Cardiomyopathy
Intervention: Device: Three-lead CRT-D (Defibrillator)
34 Unknown  The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study
Conditions: Cardiomyopathy;   Heart Failure
Interventions: Drug: POMx, pomegranate polyphenol extract;   Drug: Sugar Pill
35 Not yet recruiting Bromocriptine in the Treatment of Peripartum Cardiomyopathy
Condition: Peripartum Cardiomyopathy
Interventions: Drug: Bromocriptine;   Other: Guideline-driven medical therapy (GDMT)
36 Unknown  CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)
Condition: Inflammatory Cardiomyopathy
Interventions: Drug: Combination of prednisone and azathioprine;   Other: No intervention
37 Not yet recruiting Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy
Condition: Ischemic Cardiomyopathy
Interventions: Biological: WJMSCs Vs. placebo;   Biological: Placebo
38 Unknown  Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy
Condition: Peripartum Cardiomyopathy
Intervention: Drug: Bromocriptine
39 Recruiting PHOspholamban RElated CArdiomyopathy STudy - Intervention
Condition: Phospholamban R14del Mutation-related Cardiomyopathy
Intervention: Drug: Eplerenone
40 Recruiting Contribution Of Nuclear Magnetic Resonance Imaging In The Study Of Diabetic Cardiomyopathy
Conditions: Diabetic;   Cardiomyopathy
Intervention: Other: NUCLEAR MAGNETIC RESONANCE IMAGING

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years